- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
Policy Recommendations Missouri
2020-21 Improvements and Recommendations
Despite the approval of Amendment 2 in the 2018 election, Missouri regulators and industry have been slow to fully implement the program. At the beginning of 2021, roughly 260 of the 370 cannabis entities awarded operating licenses required an extension because they were unable to open within one year of receiving their license. However, despite this delay, the program is beginning to operate in full swing. Regulators report more businesses are opening, which not only ensures that patients have access to a dispensary, but also that the cost of medicine is going down while product selection and availability increase.
In the upcoming legislative session, Missouri lawmakers should prioritize individual patient rights like DUID protections, employment protections, and housing protections for individuals complying with the law. Lawmakers should also focus on policies that would make medical cannabis and the associated costs, like registration, more affordable for people in the state. ASA recommends ending the patient registration fee, or at the very least, instituting financial hardship waivers and discounts to ensure that any patient in the state can access the medicine they need, regardless of their ability to pay for bureaucratic processes.
Share